The datasets have been curated through partnerships with industry giants including Gastro Health and Allied Digestive, according to a Jan. 24 press release.
The platform will enable bio and medtech companies to develop, test and validate GI-related therapies by leveraging the insights in the datasets.
According to data from the World Health Organization, 2 billion people annually experience some form of GI diseases. Lynx.MD offers real-world data on some of the most common, including nonalcoholic fatty liver disease, gastroesophageal reflux disease, inflammatory bowel disease and colon cancer.
